Skip to main content
. 2014 Sep 19;307(12):H1691–H1704. doi: 10.1152/ajpheart.00281.2014

Fig. 14.

Fig. 14.

A: Masson's trichrome staining (blue stain) in the LV of control animals without Adriamycin, control animals with Adriamycin, and Sirt1endo−/− Adriamycin animals 9 wk after the beginning of treatment. Quantification of fibrosis is presented in the bar graph as % of Masson's trichrome-positive area. B: CD31 staining (brown stain) in the LV of control animals without Adriamycin, control animals with Adriamycin, and Sirt1endo−/− Adriamycin animals 9 wk after the beginning of treatment. Quantification of CD31 staining is presented in the bar graph as the number of vessels per square millimeter.